ICICI Prudential Nifty Pharma Index Fund - Growth vs Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth appears stronger based on its higher star rating of 5 compared to ICICI Prudential Nifty Pharma Index Fund - Growth's rating of 2, indicating better overall performance and management. However, investors should note the tradeoff: while Kotak has a significantly lower expense ratio of 0.2012%, it also offers lower returns over the 1-year and 3-year periods compared to ICICI Prudential, which boasts returns of 24.16% and 20.83% respectively. For investors choosing between these funds, the decision may hinge on whether they prioritize higher returns or a more favorable rating and lower costs.
ICICI Prudential Nifty Pharma Index Fund - Growth
ICICI Prudential Mutual Fund
★★★★★
Other · Index Funds
Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth
Kotak Mahindra Mutual Fund
★★★★★
Other · Index Funds
| Metric | ICICI Prudential Nifty... | Kotak Nifty SDL Apr 20... |
|---|---|---|
| NAV | ₹21.42 | ₹13.39 |
| Star Rating | ★★ | ★★★★★ |
| Expense Ratio | 0.51% | 0.2012% |
| AUM | ₹163 Cr | ₹6,136 Cr |
| 1M Return | +10.68% | +0.62% |
| 3M Return | +7.56% | +1.28% |
| 6M Return | +13.89% | +2.88% |
| 1Y Return | +24.16% | +5.84% |
| 3Y CAGR | +20.83% | +7.48% |
| Risk Level | — | — |
| Fund Manager | Nishit Patel | Abhishek Bisen |